Medical Health Cluster

Pfizer

30% of Docs Say They Don’t Want Own Kids 5-11 to Get COVID Vaccine

A Medscape poll on clinicians’ confidence surrounding the COVID-19 vaccine for kids ages 5-11 showed significant hesitancy. Among physician respondents who have children in that age group, 30% said they would not want their children to be vaccinated; 9% were unsure. For nurses/advanced practice registered nurses (APRNs), more (45%) said they did […]

Read More

Pfizer COVID Vaccine Is 100% Effective in Adolescents: Study

Pfizer announced on Monday that its COVID-19 vaccine provided long-term protection against the virus in a late-stage clinical trial among adolescents ages 12-15. A two-dose series was 100% effective against COVID-19, which was measured between 7 days and 4 months after the second dose. “As the global health community works […]

Read More

Pfizer cederá la patente de su pastilla contra el Covid-19 a 95 países

Pfizer firmó un acuerdo de licencia voluntaria, por medio del cual se establece que cederá a 95 países, la patente de su pastilla contra el Covid-19, una vez que ésta haya recibido la autorización. Este martes 16 de noviembre, Pfizer y la organización Medicines Patent Pool (MPP), hicieron el anuncio de forma conjunta […]

Read More

Pfizer solicita autorización para su píldora contra Covid-19 en EU

Pfizer Inc dijo este martes que está solicitando la autorización en Estados Unidos para su píldora antiviral experimental contra el Covid-19, que redujo en un 89% la posibilidad de hospitalización o muerte de adultos con riesgo de enfermedad grave en una prueba clínica. Pfizer afirmó que completó la presentación de […]

Read More

Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

Background Before 2020, mental disorders were leading causes of the global health-related burden, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19 pandemic has created an environment where many determinants of poor mental health are exacerbated. The need for up-to-date information on the […]

Read More

Pfizer antiviral slashes COVID-19 hospitalizations

Opening a new chapter in the treatment of COVID-19—one borrowed from successfully tackling the AIDS virus—the drug behemoth Pfizer today reported upbeat results for a 5-day pill regimen to treat early infections with SARS-CoV-2. In a trial that an outside monitoring group halted early because the treatment appeared so promising, […]

Read More